References

10.3322/caac.21660

10.3322/caac.21660 · External reference

10.1126/science.1237999

10.1126/science.1237999 · External reference

10.1038/nrg2484

10.1038/nrg2484 · External reference

10.1038/s41576-019-0150-2

10.1038/s41576-019-0150-2 · External reference

10.1038/s41588-021-00791-5

10.1038/s41588-021-00791-5 · External reference

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

2013 · External reference

10.1038/s41587-020-0546-8

10.1038/s41587-020-0546-8 · External reference

10.1093/nar/gky1141

10.1093/nar/gky1141 · External reference

10.1093/nar/gkx1067

10.1093/nar/gkx1067 · External reference

10.1093/nar/gkz430

10.1093/nar/gkz430 · External reference

miRNATissueAtlas2: an update to the human miRNA tissue atlas

10.1093/nar/gkab808 · 2021 · External reference

dbDEMC 3.0: Functional Exploration of Differentially Expressed miRNAs in Cancers of Human and Model Organisms

10.1016/j.gpb.2022.04.006 · 2022 · External reference

IMOTA: an interactive multi-omics tissue atlas for the analysis of human miRNA–target interactions

10.1093/nar/gkx701 · 2017 · External reference

10.1093/nar/gkae017

10.1093/nar/gkae017 · External reference

GEDS: A Gene Expression Display Server for mRNAs, miRNAs and Proteins

2019 · External reference

10.1093/nar/gkv1507

10.1093/nar/gkv1507 · External reference

The MicroRNA Family Gets Wider: The IsomiRs Classification and Role

10.3389/fcell.2021.668648 · 2021 · External reference

10.32614/cran.package.sigr

10.32614/cran.package.sigr · External reference

10.1016/j.semcancer.2017.11.010

10.1016/j.semcancer.2017.11.010 · External reference

10.1093/neuonc/not151

10.1093/neuonc/not151 · External reference

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker Candidates

2022 · External reference

Vimentin promotes glioma progression and maintains glioma cell resistance to oxidative phosphorylation inhibition

10.1007/s13402-023-00844-3 · 2023 · External reference

miR‑124‑3p inhibits the viability and motility of glioblastoma multiforme by targeting RhoG.

10.3892/ijmm.2021.4902 · 2021 · External reference

Significance of Glypican-3 (GPC3) Expression in Hepatocellular Cancer Diagnosis

10.12659/msm.899198 · 2017 · External reference

Expression of glypican 3 enriches hepatocellular carcinoma development-related genes and associates with carcinogenesis in cirrhotic livers

10.1093/carcin/bgu245 · 2014 · External reference

10.3748/wjg.v21.i37.10573

10.3748/wjg.v21.i37.10573 · External reference

10.1111/pin.13322

10.1111/pin.13322 · External reference

Distinct Expression and Prognostic Value of MS4A in Gastric Cancer

10.1515/med-2018-0028 · 2018 · External reference

MS4A15 acts as an oncogene in ovarian cancer through reprogramming energy metabolism

10.1016/j.bbrc.2022.01.128 · 2022 · External reference

10.1002/jcp.28828

10.1002/jcp.28828 · External reference

Elevated expression of CST1 promotes breast cancer progression and predicts a poor prognosis

10.1007/s00109-017-1537-1 · 2017 · External reference

Identification of cystatin SN as a novel biomarker for pancreatic cancer

10.1007/s13277-014-3033-3 · 2015 · External reference

C6orf15 acts as a potential novel marker of adverse pathological features and prognosis for colon cancer

10.1016/j.prp.2023.154426 · 2023 · External reference

10.1038/onc.2008.88

10.1038/onc.2008.88 · External reference

Dual epigenetic changes in diabetes mellitus-associated pancreatic ductal adenocarcinoma correlate with downregulation of E-cadherin and worsened prognosis

10.1002/cjp2.326 · 2023 · External reference

Circulating microRNAs in Early Breast Cancer Patients and Its Association With Lymph Node Metastases

10.3389/fonc.2021.627811 · 2021 · External reference

MicroRNA-133a-3p inhibits cell proliferation, migration and invasion in colorectal cancer by targeting AQP1

10.3892/ol.2021.12910 · 2021 · External reference

miR-133a-3p Regulates Hepatocellular Carcinoma Progression Through Targeting CORO1C

10.2147/cmar.s254617 · 2020 · External reference

Novel role of miR-133a-3p in repressing gastric cancer growth and metastasis via blocking autophagy-mediated glutaminolysis

10.1186/s13046-018-0993-y · 2018 · External reference

CircTADA2A suppresses the progression of colorectal cancer via miR-374a-3p/KLF14 axis

10.1186/s13046-020-01642-7 · 2020 · External reference

m(6)A‑mediated LINC02038 inhibits colorectal cancer progression via regulation of the FAM172A/PI3K/AKT pathway via competitive binding with miR‑552‑5p

2023 · External reference

Investigation of miRNA expression profiles using cohort samples reveals potential early detectability of colorectal cancers by serum miR-26a-5p before clinical diagnosis

10.3892/ol.2022.13207 · 2022 · External reference

miR-654-5p promotes gastric cancer progression via the GPRIN1/NF-κB pathway

10.1515/med-2021-0369 · 2021 · External reference

10.1007/s10585-016-9810-1

10.1007/s10585-016-9810-1 · External reference

DIANA-miTED: a microRNA tissue expression database

10.1093/nar/gkab733 · 2021 · External reference